Caltech Longevity Startup Launchpad 2026

ILAMEE turns heart-failure risk into evidence a person can act on.

The Individualized Longevity Agent for Medical Evidence Exploration estimates four-year survival, explains the factors shaping an individual result, and finds validated literature about how those most important factors are associated with reduced or increased chronic heart-failure risk.

Built in 30 hoursHealthcare AISurvival analysisExplainable AIEvidence exploration
ILAMEE team members Andrea Loizidou, Panayiotis Petousis, and Andreas Aristidou during the Caltech Longevity Startup Launchpad
The RootSquare team behind ILAMEE: Andrea Loizidou, Panayiotis Petousis, and Andreas Aristidou.

The challenge

Good evidence exists. Access to it does not.

Sudden cardiac death accounts for up to half of mortality in chronic heart failure. Heart failure affects an estimated 64 million people globally and half die within five years, yet fewer than 20% of high-risk patients receive formal risk stratification. Existing scores often require a complete laboratory panel and return one unexplained number—without a personalized reading list connecting that result to the underlying evidence.

Project presentation

See ILAMEE in action.

Watch the team’s 90-second walkthrough of the personalized risk, explanation, and evidence-exploration workflow.

Research foundation

Developed on a prospective, multicenter heart-failure cohort.

The core logistic-regression model was developed using the public MUSIC study (MUerte Súbita en Insuficiencia Cardiaca), collected from April 2003 through December 2004. It produces a four-year survival probability from whatever patient data is available and quantifies uncertainty when values are missing.

Andrea Loizidou beside the Caltech sign during the 2026 longevity event
Andrea Loizidou at Caltech during the 2026 event.
992ambulatory chronic heart-failure patients
8Spanish university hospitals
44 monthsmedian follow-up
2 outcomessudden cardiac death and pump-failure death

Three-layer agent

From prediction to personalized evidence.

ILAMEE connects risk modeling, transparent explanation, and literature retrieval in one workflow.

01 · RISK

Estimate survival

Logistic regression provides a transparent four-year survival probability and uncertainty for missing values. Cox Proportional Hazards and XGBoost models are ready as deeper-analysis tiers, with the third tier reaching a C-index of 0.753.

02 · EXPLAIN

Show what matters

SHAP values translate the model output into plain language and identify the personal factors contributing most strongly to the individual risk estimate.

03 · ACT

Connect factors to evidence

The user receives validated findings from peer-reviewed literature about how changes in their most important factors are associated with reducing or increasing chronic heart-failure risk. Automated PubMed queries tailor the evidence to the individual profile.

ILAMEE is a hackathon research prototype for evidence exploration and decision support. It is not a medical device and does not replace evaluation or treatment by a qualified clinician.

Technical foundation

Machine learning, explainability, and agentic retrieval.

PythonXGBoostCox PHlifelinesRandom Survival Forestscikit-survivalSHAPscikit-learnClaudeLangChainPubMed APIReact NativeExpoTypeScriptZustandFastshot AI

The team

Built by RootSquare.

Panayiotis Petousis, PhD

Biomedical Engineering, UCLA · Senior Data Scientist, UCLA Health

Andrea Loizidou, MS

Data Science, FIU · Data Scientist, XM

Andreas Aristidou, PhD, MS

Economics & Computer Science, USC · Senior Data Scientist, Netflix

Submitted to Devpost by the RootSquare team for the Longevity Startup Launchpad 2026.

Healthcare AI

Building a high-stakes AI workflow?

We design explainable systems that connect prediction, evidence, and human judgment.

Discuss your AI project →